Drug intelligence / Profile preview

Ec1-LoPE

Development stage
Preclinical
Lead developer
KTH Royal Institute of Technology
Modality
Bacterial Toxin Conjugates → Immunotoxins → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
Administration
Intraperitoneal, Intravenous
01

Overview

Ec1-LoPE is a recombinant fusion protein consisting of the epithelial cell adhesion molecule (EpCAM)-targeting designed ankyrin repeat protein (DARPin) Ec1 fused to a low-immunogenicity variant of Pseudomonas exotoxin A (LoPE). It is designed to selectively bind to EpCAM-expressing cancer cells, undergo receptor-mediated endocytosis, and deliver the cytotoxic toxin payload to inhibit protein synthesis and induce cell death. Ec1-LoPE has been investigated in preclinical studies for the treatment of various EpCAM-expressing malignancies, including ovarian cancer, prostate cancer, pancreatic cancer, and breast cancer, both as a monotherapy and in combination with other targeted therapies such as trastuzumab or seribantumab.

Other names
DARPin Ec1-LoPEEC1-LoPEEC-1-LoPEEC 1-LoPEEc1-LoPE fusion proteinEc-1-LoPE fusion proteinEc 1-LoPE fusion protein
02

Targets

EPCAM (Epithelial cell adhesion molecule)

Beyond the preview

Go deeper on Ec1-LoPE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ec1-LoPE.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call